BRYHALI
BRYHALI
Approved
DIN Number
02506262
Drug Class
Human
Market Date
Aug 6, 2021
Company
HC
bausch health, canada inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02506262
AIG Number0123416002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
D07AC21 ULOBETASOL
Product Specifications
Dosage FormLotion
Route of AdministrationTopical
AHFS Classification84:06.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
HALOBETASOL PROPIONATEActive
Strength: 0.01 % / W/W
Monograph: HALOBETASOL PROPIONATE